Human immunodeficiency virus-associated dementia.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Archives of Neurology

• Publication date

  2000-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHNEUR.57.3.321PMID 10714656
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Randomized trial of the platelet-activating factor antagonist lexipafant in HIV–associated cognitive impairment

  1999cited by this paper
• Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy

  1999cited by this paper
• A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment

  1998cited by this paper
• A phase I/II trial of nimodipine for HIV-related neurologic complications

  1998cited by this paper
• Neuronal injury associated with HIV-1: approaches to treatment.

  1998cited by this paper
• A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders.

  1998cited by this paper
• Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment.

  1998cited by this paper
• Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function

  1998cited by this paper
• Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group.

  1997cited by this paper
• Zidovudine therapy and HIV encephalitis: a 10‐year neuropathological survey

  1994cited by this paper
• Zidovudine treatment of the AIDS dementia complex: Results of a placebo‐controlled trial

  1993cited by this paper
• Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus‐type 1 (HIV‐1) infection

  1991cited by this paper
• Declining incidence of AIDS dementia complex after introduction of zidovudine treatment.

  1989cited by this paper
• Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection

  1988cited by this paper
• Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex.

  1988cited by this paper
• Equipoise and the ethics of clinical research.

  1987cited by this paper
• The AIDS dementia complex: I. Clinical features

  1986cited by this paper

• Underestimated virus impaired cognition-more evidence and more work to do

  2025cites this paper
• Lithium salts in AIDS and AIDS-related dementia.

  2025cites this paper
• SARS-CoV-2 and Parkinson’s Disease: A Review of Where We Are Now

  2023cites this paper
• HIV-Associated Vacuolar Myelopathy and HIV-Associated Neurocognitive Disorder as an Initial Presentation in HIV Infection

  2023cites this paper
• Sociodemographic Characteristics of HIV-Associated Dementia in the South Carolina Alzheimer’s Disease Registry

  2023cites this paper
• Viruses, parkinsonism and Parkinson’s disease: the past, present and future

  2022cites this paper
• Cognitive Assessment of Young Adults Before and After Initiation of Combination Antiretroviral Therapy

  2022cites this paper
• Meta-Analysis on Nicotine's Modulation of HIV-Associated Dementia

  2021cites this paper
• Co-receptor signaling in the pathogenesis of neuroHIV

  2021cites this paper
• HIV-Associated Neurocognitive Disorder (HAND)

  2020cites this paper
• [Characteristics of psychopathological symptomatology in HIV-infection schizophrenic patients].

  2017cites this paper
• HIV Infection Comorbid with Psychiatric Disorders: Five Case Reports

  2016cites this paper
• PATHOGENIC MECHANISMS OF HIV-1 ENCEPHALITIS

  2016cites this paper
• Impact of cocaine abuse on HIV pathogenesis

  2015cites this paper
• A Novel Role of Proline Oxidase in HIV-1 Envelope Glycoprotein-induced Neuronal Autophagy*

  2015cites this paper
• Reduced neural specificity in middle-aged HIV+ women in the absence of behavioral deficits

  2014cites this paper
• HIV-associated neurocognitive disorder.

  2013cites this paper
• Astrocytic expression of HIV-1 Nef impairs spatial and recognition memory.

  2013cites this paper
• Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection

  2013cites this paper
• Effects of opiates and HIV proteins on neurons: the role of ferritin heavy chain and a potential for synergism.

  2012cites this paper
• White matter dementia

  2012cites this paper
• Gene Expression Profiles in GP160-Expressing Mouse Model of HIV-Associated Dementia

  2012cites this paper
• Chapter 19 – Primary neurological manifestation of HIV/AIDS

  2012cites this paper
• Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: Data from the Italian Registry Investigative Neuro AIDS (IRINA)

  2011cites this paper
• of NeuroAIDS Neuroprotective Activities of CEP-1347 in Models

  2011cites this paper
• The Central Nervous System Manifestations of HIV-1 Infection in the Combination Antiretroviral Therapy Era

  2011cites this paper
• Characterization of peripheral blood human immunodeficiency virus isolates from Hispanic women with cognitive impairment

  2011cites this paper
• Development of neurocognitive disorders in HIV/AIDS

  2011cites this paper
• The ageing of HIV: implications for geriatric medicine.

  2010cites this paper
• Cognitive strategy application during everyday task performance in men with HIV-1 dementia

  2010cites this paper
• Imaging evaluation of demyelinating processes of the central nervous system

  2010cites this paper
• A guide to neuropsychological testing for health care professionals

  2010cites this paper
• HIV DNA in circulating monocytes as a mechanism to dementia and other HIV complications

  2010cites this paper
• Neurological Complications of Hiv Infection

  2010cites this paper
• Dopaminergic neurotoxicity of HIV-1 gp120: reactive oxygen species as signaling intermediates.

  2010cites this paper
• Human immunodeficiency virus‐associated neurocognitive disorders: Mind the gap

  2010cites this paper
• Pearls: Neurologic Complications of HIV/AIDS

  2010cites this paper
• Soins palliatifs et SIDA à l'hôpital local de Pompey : étude sur 43 cas

  2010cites this paper
• Etica médica y humanismo

  2010cites this paper
• HIV-associated neurocognitive disorders: is there a hidden epidemic?

  2010cites this paper
• Involvement of quinolinic acid in aids dementia complex

  2009cites this paper
• Usefulness of the HIV Dementia Scale in Nigerian patients with HIV / AIDS : original article

  2009cites this paper
• Proinflammatory cytokines and HIV‐1 synergistically enhance CXCL10 expression in human astrocytes

  2009cites this paper
• Methamphetamine abuse, HIV infection, and neurotoxicity.

  2009cites this paper
• Neuroprotective Activities of CEP-1347 in Models of NeuroAIDS

  2009cites this paper
• Models of NeuroAIDS Neuroprotective Activities of CEP-1347 in

  2009cites this paper
• IGF-IR in neuroprotection and brain tumors.

  2009cites this paper
• HIV Infection and the Central Nervous System: A Primer

  2009cites this paper
• Nonhuman primate models of NeuroAIDS

  2008cites this paper
• HIV and AIDS

  2008cites this paper
• Evolution of HIV dementia with HIV infection

  2008cites this paper
• Transcription Factor FOXO3a Mediates Apoptosis in HIV-1-Infected Macrophages1

  2008cites this paper
• Impaired Astrocytes and Diffuse Activation of Microglia in the Cerebral Cortex in Simian Immunodeficiency Virus-Infected Macaques Without Simian Immunodeficiency Virus Encephalitis

  2008cites this paper
• Primary Neurological Manifestation of HIV/AIDS

  2008cites this paper
• Sera proteomic biomarker profiling in HIV‐1 infected subjects with cognitive impairment

  2008cites this paper
• Classification of HIV-I-Mediated neuronal dendritic and synaptic damage using multiple criteria linear programming

  2007influential citation
• HIV-1 envelope glycoprotein 120 induces cyclooxygenase-2 expression in astrocytoma cells through a nuclear factor-κB-dependent mechanism

  2007cites this paper
• (Peri)vascular production and action of pro-inflammatory cytokines in brain pathology.

  2007cites this paper
• Memory Performance in HIV/AIDS - A Prospective Case Control Study

  2007cites this paper
• PDGF Synergistically Enhances IFN-γ-Induced Expression of CXCL10 in Blood-Derived Macrophages: Implications for HIV Dementia1

  2007cites this paper
• In vivo Models of HIV Disease and Control

  2006cites this paper
• The immunophilin ligand GPI1046 protects neurons from the lethal effects of the HIV‐1 proteins gp120 and Tat by modulating endoplasmic reticulum calcium load

  2006cites this paper
• HIV‐1‐based defective lentiviral vectors efficiently transduce human monocytes‐derived macrophages and suppress replication of wild‐type HIV‐1

  2006cites this paper
• TRAIL-Mediated Apoptosis in HIV-1-Infected Macrophages Is Dependent on the Inhibition of Akt-1 Phosphorylation1

  2006cites this paper
• [Inflammatory reconstitution immune syndrome associated to antiretroviral therapy and meningeal cryptococcosis].

  2006cites this paper
• Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment

  2006cites this paper
• Molecular mechanisms of HIV-1 associated neurodegeneration

  2005cites this paper
• Mechanisms of HIV-1 Inhibition by the Lipid Mediator N-Arachidonoyldopamine1

  2005cites this paper
• Neuropsychopathology in the SIV/macaque model of AIDS.

  2005cites this paper
• Neurological complications of HIV infection.

  2005cites this paper
• Neurologic and Psychiatric Complications of Antiretroviral Agents

  2005cites this paper
• HIV-1 infection and AIDS: consequences for the central nervous system

  2005cites this paper
• Experimental and potential future therapeutic approaches for HIV-1 associated dementia targeting receptors for chemokines, glutamate and erythropoietin

  2005cites this paper
• Prevention of AIDS Dementia by HAART Does Not Depend on Cerebrospinal Fluid Drug Penetrance

  2004cites this paper
• Impaired Performance on a Rhesus Monkey Neuropsychological Testing Battery following Simian Immunodeficiency Virus Infection

  2004cites this paper
• HIV Infection and the Central Nervous System

  2004cites this paper
• Guidelines for the diagnosis and management of neurological complications of HIV infection

  2004cites this paper
• Sedimentation velocity studies of the high–molecular weight aggregates of the HIV gp41 ectodomain

  2004cites this paper
• Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms.

  2004influential citation
• Cerebrospinal fluid and plasma concentrations of proinflammatory mediators in human immunodeficiency virus-infected children

  2004cites this paper
• HIV-1/AIDS Neuropathology in a Canadian Teaching Centre

  2004cites this paper
• Human CNS cultures exposed to HIV-1 gp120 reproduce dendritic injuries of HIV-1-associated dementia

  2004cites this paper
• Stromal cell‐derived factor 1‐mediated CXCR4 signaling in rat and human cortical neural progenitor cells

  2004cites this paper
• Growth hormone prevents human immunodeficiency virus–induced neuronal p53 expression

  2003cites this paper
• Whole brain imaging of HIV-infected patients: quantitative analysis of magnetization transfer ratio histogram and fractional brain volume.

  2003cites this paper
• Chapter 18 – Neurologic Complications of HIV and AIDS

  2003cites this paper
• Tracking superparamagnetic iron oxide labeled monocytes in brain by high‐field magnetic resonance imaging

  2003cites this paper
• Human Immunodeficiency Virus Infections—Neurological Manifestations

  2003cites this paper
• Central nervous system correlates of behavioral deficits following simian immunodeficiency virus infection

  2003influential citation
• Clinical implications of HIV-1 drug resistance in the neurological compartment

  2003cites this paper
• Neuropathogenesis of central nervous system HIV-1 infection.

  2002cites this paper
• Risk factors for cognitive impairment in HIV-1-infected persons with different risk behaviors.

  2002cites this paper
• [Cognitive impairment in a 35 years-old male].

  2002cites this paper
• Trends in Diseases Reported on U.S. Death Certificates That Mentioned HIV Infection, 1987‐1999

  2002cites this paper
• Progress in Clinical Neurosciences: The Neuropathogenesis of HIV Infection: Host-Virus Interaction and the Impact of Therapy

  2002cites this paper
• Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients

  2002cites this paper
• Interactions of human immunodeficiency virus‐1 proteins with neurons: possible role in the development of human immunodeficiency virus‐1‐associated dementia

  2002cites this paper
• Accumulation of β‐Amyloid Precursor Protein in Axons Correlates with CNS Expression of SIV gp41

  2002influential citation
• A randomized clinical trial of CPI-1189 for HIV-associated cognitive–motor impairment

  2002cites this paper
• Comorbid conditions, treatment, and health maintenance in older persons with human immunodeficiency virus infection in New York City.

  2002cites this paper